Sun Yi Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sun Yi Choi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Dong Kun Lee
Department of Otorhinolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea
1 shared publication - Eun Nam Lee
College of Nursing, Dong-A University, Busan 49201, Korea
1 shared publication - Heon Soo Park
Department of Otolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea
1 shared publication - Hyoung Shin Lee
Department of Otolaryngology Head and Neck Surgery, Kosin University College of Medicine, Busan, Korea
1 shared publication - Jong Chul Hong
Department of Otolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea
1 shared publication - Kang Dae Lee
Department of Otolaryngology-Head and Neck Surgery, Kosin University College of Medicine, Busan, Korea
1 shared publication
Latest Publications
- Open Access
- 14 November 2013
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 11 (1) , 291
The relationship between the BRAFV600E mutation in papillary thyroid microcarcinoma and clinicopathologic factors
The BRAFV600E mutation, which accounts for about 60–80% papillary thyroid carcinoma(PTC), has been identifiedas a prognostic marker for risk stratification of PTC patients. However, the BRAFV600E mutation as a prognostic marker in papillary thyroid microcarcinoma (PTMC) is unclear. We performed a retrospective review of 101 patients who underwent surgery for PTMC. We studied the prevalence of the BRAFV600E mutation. The associations between the BRAFV600E mutation and clinicopathologic characteristics were analyzed. The BRAFV600E mutation was observed in 72 patients (71.3%). There was no statistically significant correlation in age, gender, multifocality, extrathyroidal extension, presence of Hashimoto thyroiditis, and lymph node metastasis between the BRAFV600E mutant group and wild group. The BRAFV600E mutation is not significantly associated with prognostic factors in PTMC.
- 14 November 2013
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 11 (1) , 291
Open AccessThe relationship between the BRAFV600E mutation in papillary thyroid microcarcinoma and clinicopathologic factors
The BRAFV600E mutation, which accounts for about 60–80% papillary thyroid carcinoma(PTC), has been identifiedas a prognostic marker for risk stratification of PTC patients. However, the BRAFV600E mutation as a prognostic marker in papillary thyroid microcarcinoma (PTMC) is unclear. We performed a retrospective review of 101 patients who underwent surgery for PTMC. We studied the prevalence of the BRAFV600E mutation. The associations between the BRAFV600E mutation and clinicopathologic characteristics were analyzed. The BRAFV600E mutation was observed in 72 patients (71.3%). There was no statistically significant correlation in age, gender, multifocality, extrathyroidal extension, presence of Hashimoto thyroiditis, and lymph node metastasis between the BRAFV600E mutant group and wild group. The BRAFV600E mutation is not significantly associated with prognostic factors in PTMC.